# URO-1

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uro-1

- Industry: Medical Devices & Equipment
- Headquarters: Winston-Salem, US
- Website: www.uro1medical.com/
- Total disclosed funding: $1.1M
- Latest round: Series A (Sep 6, 2017)
- Investors on record: 1

## About

Founded in 2017 and based in North Carolina, US, URO-1 Inc. operates as a medical device manufacturer providing solutions for office-based urology and urogynecology procedures. As of 2024, the company is headed by its CEO Ted Belleza. In February 2024, the firm raised USD 8 million in Series A funding led by investor Acorn Campus Ventures, with participation from individual investors.

The company offers medical devices for the diagnosis and treatment of urologic disorders. The firm products are used in prostate biopsy for men as well as for the treatment of overactive bladder (OAB) in women. The firm product range includes SUREcore Prostate Biopsy Needle, coreCARE Specimen Retrieval Kit, and intravesical injection.

The company plans to use the February 2024 funding to scale up the production of its SUREcore needle product.

## Funding rounds

- Series A, Sep 6, 2017, $1.1M — Acorn Campus Ventures

## Investors

- Acorn Campus Ventures (https://capitalatlas.ai/funds/acorn-campus-ventures) — Series A